PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance

Overview of attention for article published in Frontiers in Cell and Developmental Biology, September 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 5 news outlets
twitter: 12 X users

patent: 2 patents

Readers on

mendeley: 649 Mendeley

Summary News X Patents

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 166,179 followers.

RT @FrontCellDevBio: Have you read our review article "PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance" by D…

07 Nov 2022

Reply Repost Favourite

RT @FrontCellDevBio: Have you read our review article "PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance" by D…

07 Nov 2022

Reply Repost Favourite

Have you read our review article "PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance" by Dr. Rose, Dr, Burgess, Dr. O’Byrne, Dr. Richard and Dr. Bolderson? 👉Dont miss out: https://t.co/cKkirXpvGa #OpenAccess #Review https://

07 Nov 2022

Reply Repost Favourite

RT @FrontiersIn: Review article: Poly (ADP-ribose) polymerase (PARP) Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resista…

05 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.